Skip to main content
915 TLDR
Health
1 read

Trump's Executive Order Aims to Expedite Ibogaine Drug Review Process

KTSM••Patrick Djordjevic
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

On Saturday, President Trump signed an executive order to accelerate the review process for psychedelic substances, notably including ibogaine. This move is significant as it may pave the way for broader acceptance and potential therapeutic uses of ibogaine, which is derived from the iboga plant and has been studied for its effects on addiction treatment. The order could impact various stakeholders, including researchers, healthcare providers, and patients seeking alternative treatments. The implications of this order may lead to changes in drug policy and availability in the near future.

trump drug-policy ibogaine psychedelic

People & Organizations

Donald Trump

Related Articles

KVIA•Jun 2

Passengers Exposed to Hantavirus Complete Quarantine at Home After Cruise

Several U.S. passengers who were exposed to a rare strain of hantavirus aboard a cruise this spring have returned home to finish their mandatory six-week quarantine. Five individuals have been discharged from the National Quarantine Unit, while thirteen remain under observation, with some expected to leave soon. The CDC confirmed that these individuals show no symptoms and meet health criteria for home monitoring. Public health officials will continue daily symptom checks until June 21, ensuring community safety. The CDC emphasized the importance of avoiding stigma against those being monitored, as public health measures are in place to protect everyone.

Health
1 min read
KVIA•Jun 2

Cruise Ship Passengers Exposed to Hantavirus Complete Quarantine at Home

Several American cruise ship passengers exposed to a rare hantavirus strain have returned home to finish their six-week quarantine. Five individuals have been released from the National Quarantine Unit, while thirteen others remain under monitoring, with some expected to leave soon. The CDC is overseeing the situation, ensuring that those monitored are symptom-free and have met health criteria. The public is urged to avoid stigmatizing these individuals, as the monitoring is a precautionary measure. The quarantine period will conclude on June 21, with state health departments conducting daily checks.

Health
1 min read
KVIA•Jun 1

Measles Case Reported at Deming Detention Center Raises Health Concerns

A federal inmate at the Luna County Detention Center in Deming, New Mexico, has tested positive for measles, marking the 16th case reported in the state this year. The New Mexico Department of Health (NMDOH) has identified a potential exposure site at the U.S. Probation & Parole Office in Las Cruces on May 27, between 8:30 a.m. and 2 p.m. Symptoms of measles can develop within 7 to 21 days after exposure, including fever, cough, and a characteristic rash. NMDOH emphasizes the importance of the measles, mumps, and rubella (MMR) vaccine as a preventive measure against the disease.

Health
1 min read
KTSM•Jun 1

Measles Outbreak: Inmate at Luna County Jail Tests Positive

A federal inmate at the Luna County Detention Center in Deming, New Mexico, has been confirmed to have measles, marking the 16th case reported in the state this year. The New Mexico Department of Health has issued warnings about possible exposure to the virus at the facility. This incident highlights ongoing public health concerns and the need for vigilance regarding vaccination and disease prevention. Residents and visitors in the area should remain aware of the situation and monitor for symptoms.

Health
1 min read